Skip to main content
Top
Published in: European Journal of Applied Physiology 4/2018

01-04-2018 | Invited Review

Opinion paper: scientific, philosophical and legal consideration of doping in sports

Authors: Massimo Negro, Natale Marzullo, Francesca Caso, Luca Calanni, Giuseppe D’Antona

Published in: European Journal of Applied Physiology | Issue 4/2018

Login to get access

Abstract

The term doping is generally used to indicate practices based on the use of performance-enhancing drugs (PEDs) or the abuse of medical therapies. Mostly analysed by doctors and officials, doping nevertheless also requires a philosophical consideration to avoid being simplistically portrayed as an isolated practice. To do this, we need to pay attention to the contradictions and paradoxes in the modern approach to doping in sport. In this context, doping is not only relevant to the health of an individual involved in the violation of World Anti-Doping Agency (WADA) criteria, but it actually represents a double-edged phenomenon containing ethical and legal points of view. Several philosophical items affect the ethics of doping. While, indeed, through a deontological vision it is easy to morally condemn an athlete who takes the decision to turn to doping, the same condemnation becomes difficult when the practice of doping is compared with the strong social demand of winners in every field of life. This point must be considered to prevent doping from becoming accepted as a daily practice to excel at all costs and regarded not only as normal but as a necessity for those participating in sport at both an amateur and professional level. Furthermore, a complete discussion on doping has to consider not only the philosophy of performance-enhancing drug abuse, but also the widespread practice of an inappropriate and excessive intake of certain dietary supplements with the unique and obsessive purpose (similar to doping) of increasing physical or mental performance. Based on the above, the aim of this paper is to provide a critical opinion of the doping problem and its related practices and analyze possible solutions considering issues that go beyond the impact of doping on health and reflect on whether it is right or not that an athlete does all he can to improve his performance.

Graphical Abstract

Literature
go back to reference Budnitz DS, Pollock DA, Weidenbach KN et al (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296:1858–1866CrossRefPubMed Budnitz DS, Pollock DA, Weidenbach KN et al (2006) National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296:1858–1866CrossRefPubMed
go back to reference Casini L (2012) The making of a lex sportiva by the Court of Arbitration of sports. In: Siekmann R, Soek J (eds) Lex Sportiva: what is sport law? ASSER International Sports Law Series. C. Asser Press, T. M., pp 149–171CrossRef Casini L (2012) The making of a lex sportiva by the Court of Arbitration of sports. In: Siekmann R, Soek J (eds) Lex Sportiva: what is sport law? ASSER International Sports Law Series. C. Asser Press, T. M., pp 149–171CrossRef
go back to reference Cohen PA (2012) Assessing supplement safety—the FDA’s controversial proposal. N Engl J Med 366:389–391CrossRefPubMed Cohen PA (2012) Assessing supplement safety—the FDA’s controversial proposal. N Engl J Med 366:389–391CrossRefPubMed
go back to reference Colucci M (2010) Sports law in Italy. Wolters Kluwer—Law & Business, Austin Colucci M (2010) Sports law in Italy. Wolters Kluwer—Law & Business, Austin
go back to reference Dambrova M, Liepinsh E (2016) Response to comment by Sergei V. Jargin: “Meldonium (Mildronate): primum nоn nocere”. Pharmacol Res 114:295–296CrossRefPubMed Dambrova M, Liepinsh E (2016) Response to comment by Sergei V. Jargin: “Meldonium (Mildronate): primum nоn nocere”. Pharmacol Res 114:295–296CrossRefPubMed
go back to reference Derrida J (1995) The rhetoric of drugs. In: Weber E (ed) Points… Interviews, 1974–1994. Stanford University Press, Stanford CA, pp 228–254 Derrida J (1995) The rhetoric of drugs. In: Weber E (ed) Points… Interviews, 1974–1994. Stanford University Press, Stanford CA, pp 228–254
go back to reference Duret P, Wolff M (1994) The semiotics of sports heroism. Int Rev Soc Sport 29:135–145CrossRef Duret P, Wolff M (1994) The semiotics of sports heroism. Int Rev Soc Sport 29:135–145CrossRef
go back to reference Foucault M (1977) Discipline and punish: the Birth of the prison (translated from the French by Alan Sheridan). Vintage Books a division of random house, New York Foucault M (1977) Discipline and punish: the Birth of the prison (translated from the French by Alan Sheridan). Vintage Books a division of random house, New York
go back to reference Geller AI, Shehab N, Weidle NJ et al (2015) Emergency department visits for adverse events related to dietary supplements. N Engl J Med 373:1531–1540CrossRefPubMed Geller AI, Shehab N, Weidle NJ et al (2015) Emergency department visits for adverse events related to dietary supplements. N Engl J Med 373:1531–1540CrossRefPubMed
go back to reference Greenblatt HK, Greenblatt DJ (2016) Meldonium (Mildronate): a performance-enhancing drug? Clin Pharmacol Drug Dev 5:167–169CrossRefPubMed Greenblatt HK, Greenblatt DJ (2016) Meldonium (Mildronate): a performance-enhancing drug? Clin Pharmacol Drug Dev 5:167–169CrossRefPubMed
go back to reference La Gerche A, Brosnan MJ (2017) cardiovascular effects of performance-enhancing drugs. Circulation 135:89–99CrossRefPubMed La Gerche A, Brosnan MJ (2017) cardiovascular effects of performance-enhancing drugs. Circulation 135:89–99CrossRefPubMed
go back to reference Liepinsh E, Konrade I, Skapare E et al (2011) Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers. J Pharm Pharmacol 63:1195–1201CrossRefPubMed Liepinsh E, Konrade I, Skapare E et al (2011) Mildronate treatment alters γ-butyrobetaine and l-carnitine concentrations in healthy volunteers. J Pharm Pharmacol 63:1195–1201CrossRefPubMed
go back to reference Miah A (2004) Genetically modified athletes. Biomedical ethics, gene doping and sport. Routledge (Taylor & Francis Group), London and New York Miah A (2004) Genetically modified athletes. Biomedical ethics, gene doping and sport. Routledge (Taylor & Francis Group), London and New York
go back to reference Mottram DR, Chester N (2015) Prohibited supplements. In: Mottram DR, Chester N (eds) Drugs in Sport, 6th edn. Routledge (Taylor & Francis Group), London and New York, p 335 Mottram DR, Chester N (2015) Prohibited supplements. In: Mottram DR, Chester N (eds) Drugs in Sport, 6th edn. Routledge (Taylor & Francis Group), London and New York, p 335
go back to reference Navarro V, Khan I, Björnsson E et al (2017) liver injury from herbal and dietary supplements. Hepatology 65(1):363–373CrossRefPubMed Navarro V, Khan I, Björnsson E et al (2017) liver injury from herbal and dietary supplements. Hepatology 65(1):363–373CrossRefPubMed
go back to reference Pope HG Jr, Wood RI, Rogol A et al (2014) Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev 35:341–375CrossRefPubMed Pope HG Jr, Wood RI, Rogol A et al (2014) Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev 35:341–375CrossRefPubMed
go back to reference Schobersberger W, Dünnwald T, Gmeiner G et al (2017) Story behind meldonium-from pharmacology to performance enhancement: a narrative review. Br J Sports Med 51:22–25CrossRefPubMed Schobersberger W, Dünnwald T, Gmeiner G et al (2017) Story behind meldonium-from pharmacology to performance enhancement: a narrative review. Br J Sports Med 51:22–25CrossRefPubMed
Metadata
Title
Opinion paper: scientific, philosophical and legal consideration of doping in sports
Authors
Massimo Negro
Natale Marzullo
Francesca Caso
Luca Calanni
Giuseppe D’Antona
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Applied Physiology / Issue 4/2018
Print ISSN: 1439-6319
Electronic ISSN: 1439-6327
DOI
https://doi.org/10.1007/s00421-018-3821-3

Other articles of this Issue 4/2018

European Journal of Applied Physiology 4/2018 Go to the issue